Heptares Therapeutics

Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets. The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, Stabilised Receptors), overcoming a major limiting factor to the development of new drugs targeting this group.
Type
Subsidiary
HQ
Welwyn Garden City, GB
Founded
2007
Size (employees)
76 (est)
Heptares Therapeutics was founded in 2007 and is headquartered in Welwyn Garden City, GB

Heptares Therapeutics Office Locations

Heptares Therapeutics has offices in Welwyn Garden City, Welwyn Garden City, AL7 3AX
Welwyn Garden City, GB
Welwyn Garden City, AL7 3AX, GB

Heptares Therapeutics Metrics

Heptares Therapeutics Summary

Founding Date

2007

Total Funding

$21 m

Investors

Heptares Therapeutics Financials

We estimate that Heptares Therapeutics's revenue is £5.2 m in FY, 2014
FY, 2014

Revenue

£5.2 m

Heptares Therapeutics Online Presence

Heptares Therapeutics Company Life

You may also be interested in